Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Novel discovery in gene therapy to treat kidney diseases …
Newer Targets
Stanford researchers program cancer-fighting cells to resist exhaustion, attack solid tumors…
Newer Targets
Dyno Therapeutics Announces Research Published in Science Enabling Artificial Intelligence Approach…
Newer Targets
Hepion Pharmaceuticals’ CRV431 Prevents Cirrhosis in Experimental Model of Severe Liver…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
FDA Committee Votes 6-6 on Durect’s Non-Opioid Pain Drug
Approval
Novo Nordisk’s Ozempic Wins Approval for Reducing Cardiovascular Events in Diabetes…
Clinical
FDA advisory panel split on whether to approve Durect’s Posimir for…
Approval
Breast cancer patients to have further NICE-approved drug combination option on…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Seneca Biopharma Surges Near 113% After Comments on Seeking Partnership for…
Deals
TB Alliance Announces Partnership with Hongqi Pharma to Commercialize New Therapy…
Commercial
US judge hacks $8-billion damages verdict against Johnson & Johnson in…
Deals
JPM Day 3: High Prices in San Francisco Are a Problem,…
Home
Therapy areas
Immuno-oncology
Immuno-oncology
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Immuno-oncology
Activation of a distinct genetic pathway can slow the progress of metastatic breast cancer ...
Firstwordpharma News
-
January 17, 2020
Immuno-oncology
Cancers engaged in evolutionary arms race with immune system
Immuno-oncology
AI Therapeutics Announces that a Common LAM-002 Mechanism in Cancer and Neurodegenerative Diseases Shows Antitumor Activity in the Clinic and Hope for ALS
Immuno-oncology
Bellicum Pharmaceuticals to Present New Translational Data for BPX-601 at ASCO 2020 Gastrointestinal Cancers Symposium
Immuno-oncology
Larotrectinib in tumours with NTRK gene fusion: Data are not yet sufficient for derivation of an added benefit
Immuno-oncology
NICE issues draft guidance rejecting Merck & Co.’s Keytruda in first-line...
Firstwordpharma News
-
January 15, 2020
0
Immuno-oncology
Hoth Therapeutics Exercises Patent Licensing Option with the George Washington University...
Firstwordpharma News
-
January 15, 2020
0
Immuno-oncology
BioLineRx Receives Orphan Drug Designation for Motixafortide (BL-8040) for the Treatment...
Firstwordpharma News
-
January 14, 2020
0
Immuno-oncology
NantKwest says patient with pancreatic cancer achieved complete response after treatment...
Firstwordpharma News
-
January 14, 2020
0
Immuno-oncology
PHARMAC seeking views on new breast cancer medicine
Firstwordpharma News
-
January 14, 2020
0
1
2
3
...
39
Page 1 of 39
- Advertisement -
MOST POPULAR
Mankind Pharma launches drug for treatment of infertility in India ...
December 5, 2019
QIAGEN and Inovio Team Up to Create Companion Diagnostic for HPV...
May 17, 2019
NewLink Genetics Announces Exclusive Worldwide License Agreement with Ellipses Pharma for...
December 23, 2019
Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics
March 20, 2019
Load more
HOT NEWS
Others
Poxel Announces Updates to its Management Team
Others
Insight Report: Where is the Peanut Allergy Drug Pipeline Now?
Approval
Regeneron’s Eylea granted expanded US approval for diabetic retinopathy
Others
Arcutis Announces Exercise of Option for Exclusive License to Highly Selective...
